Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells

Publication date: Available online 28 September 2020Source: Hepatobiliary & Pancreatic Diseases InternationalAuthor(s): Yi-Ting Hu, Zhe-Yue Shu, Jing-Hua Jiang, Qin-Fen Xie, Shu-Sen Zheng
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research